226 related articles for article (PubMed ID: 30192876)
1. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS
PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Wang Z; Cui K; Xue Y; Tong F; Li S
Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
Wu XL; Tu Q; Faure G; Gallet P; Kohler C; Bittencourt Mde C
Sci Rep; 2016 Feb; 6():20210. PubMed ID: 26831813
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
Tinhofer I; Konschak R; Stromberger C; Raguse JD; Dreyer JH; Jöhrens K; Keilholz U; Budach V
Ann Oncol; 2014 Oct; 25(10):2042-2047. PubMed ID: 25057171
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Xun Y; Cao Q; Zhang J; Guan B; Wang M
Oral Oncol; 2020 May; 104():104638. PubMed ID: 32182549
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Dong Y; Ma G; Liu Y; Lu S; Liu L
Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
11. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
12. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
Song Q; Li X; Li B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):67-75. PubMed ID: 25966559
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
14. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
Zhang X; Weeramange CE; Hughes BGM; Vasani S; Liu ZY; Warkiani M; Hartel G; Ladwa R; Thiery JP; Kenny L; Breik O; Punyadeera C
Cell Mol Life Sci; 2024 May; 81(1):233. PubMed ID: 38780775
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
[TBL] [Abstract][Full Text] [Related]
19. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
Cho JK; Kim MW; Choi IS; Moon UY; Kim MJ; Sohn I; Kim S; Jeong HS
BMC Cancer; 2018 Oct; 18(1):969. PubMed ID: 30309318
[TBL] [Abstract][Full Text] [Related]
20. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
Wei D; Liu J; Ma J
PeerJ; 2023; 11():e16014. PubMed ID: 37719125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]